RA0485

antibody from Oursmab

Targeting: MET DFNB97, HGFR, RCCP2

Western blot (Supportive data in Antibodypedia)

ELISA (Supportive data in Antibodypedia)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0485

Provider

Oursmab

Product name

Telisotuzumab (Biosimilar Reference Antibody) (MET)

Antibody type

Monoclonal

Description

Telisotuzumab is a humanized monoclonal antibody targeting c-Met (hepatocyte growth factor receptor), a receptor tyrosine kinase involved in tumor growth and metastasis. It is developed as an antibody-drug conjugate (ADC), linked to a cytotoxic payload (e.g., a microtubule inhibitor), to deliver targeted chemotherapy to c-Met¨Coverexpressing cancer cells. It is being evaluated for the treatment of non-small cell lung cancer (NSCLC) and other solid tumors with c-Met dysregulation.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Telisotuzumab (Biosimilar Reference Antibody) (MET)-RA0485-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.

ELISA

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

ELISA plate pre-coated Antigen protein, can bind Telisotuzumab (Biosimilar Reference Antibody) (MET)-RA0485 in a linear range of 15.63¨C125 ng/mL.